Conrad and becker's "10 criteria" fall short of addressing conflicts of interest in chemical safety studies

Environmental Health Perspectives

Volumn 119, Issue 12, 2011, Pages

  Sutton, Patrice ^a   Woodruff, Tracey J ^a   Vogel, Sarah ^b   Bero, Lisa A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Johnson Family Foundation New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; ARTICLE; CHEMICAL ANALYSIS; CHEMICAL INDUSTRY; CONFLICT OF INTEREST; ENVIRONMENTAL HEALTH; EVIDENCE BASED MEDICINE; FINANCIAL MANAGEMENT; GOOD LABORATORY PRACTICE; HEALTH CARE POLICY; MEDICAL RESEARCH; PRIORITY JOURNAL; PUBLICATION; SAFETY;

EID: 82755166802     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104385     Document Type: Article

References (22)

1. Barnes DE, Bero LA. 1997. Scientific quality of original research articles on environmental tobacco smoke. Tob Control 6(1):19-26.
2. Barnes DE, Bero LA. 1998. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 279(19):1566-1570.
3. Bero LA. 1999. Accepting commercial sponsorship. Disclosure helps-but is not a panacea [Editorial]. BMJ 319(7211):653-654.
4. Bero L, Oostvogel F, Bachetti P, Lee K. 2007. Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others. PLoS Med 4(6):e184; doi:10.1371/journal.pmed.0040184 [Online 5 June 2007].
5. Bipartisan Policy Center. 2009. Improving the Use of Science in Regulatory Policy. Washington, DC:Bipartisan Policy Center.
6. Brockway LM, Furcht LT. 2006. Conflicts of interest in bio medical research-the FASEB guidelines. FASEB J 20(14):2435-2438.
7. Conrad JW Jr, Becker RA. 2011. Enhancing credibility of chemi cal safety studies: emerging consensus on key assessment criteria. Environ Health Perspect 119:757-764.
8. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ, et al. 2008. What is "quality of evi dence" and why is it important to clinicians? BMJ 336(7651):995-998.
9. Henry CJ, Conrad JW Jr. 2008. Scientific and legal perspectives on science generated for regulatory activities. Environ Health Perspect 116:136-141.
10. Higgins JPT, Green S, eds. 2006. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. The Cochrane Library, Issue 4. Chichester, UK:John Wiley & Sons, Ltd.
11. IARC (International Agency for Research on Cancer). 2008. IARC Code of Good Scientific Practice. IARC Working Group Reports Vol 4. Lyon, France:IARC.
12. Institute of Medicine. 2009. Conflicts of Interest in Medical Research, Education and Practice. Washington, DC:National Academies Press.
13. Landrigan PJ, Goldman LR. 2011. Children's vulnerability to toxic chemicals: a challenge and opportunity to strengthen health and environmental policy. Health Aff 30(5):842-850.
14. Lexchin J, Bero LA, Djulbegovic B, Clark O. 2003. Pharmaceutical industry sponsorship and research outcome and quality: systematic review. BMJ 326(7400):1167-1170.
15. Popelut A, Valet F, Fromentin O, Thomas A, Bouchard P. 2010. Relationship between sponsorship and failure rate of dental implants: a systematic approach. PLoS One 5(4):e10274; doi:10.1371/journal.pone.0010274 [Online 21 April 2010].
16. Rennie D. 2010. Integrity in scientific publishing. Health Serv Res 45(3):885-896.
17. Roseman M, Milette K, Bero LA, Coyne JC, Lexchin J, Turner EH, et al. 2011. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments. JAMA 305(10):1008-1017.
18. Rowe S, Alexander N, Clydesdale FM, Applebaum RS, Atkinson S, Black RM, et al. 2009. Funding food science and nutrition research: financial conflicts and scientific integrity. Am J Clin Nutr 89(5):1285-1291.
19. Shah RV, Albert TJ, Brugel-Sanchez V, Vaccaro AR, Hilibrand AS, Grauer JN. 2005. Industry support and correlation to study outcome for papers published in Spine. Spine 30(9):1099-1104.
20. U.S. Census Bureau. 2009. 2007 Economic Census. Available: http://factfinder.census.gov/servlet/IBQTable?_bm=y&-ds_name=EC0700CADV1 [accessed 4 November 2011].
21. Vogel SA, Roberts JA. 2011. Why The Toxic Substances Control Act needs an overhaul, and how to strengthen oversight of chemicals in the interim. Health Aff 30(5):898-905.
22. Woodruff TJ, Sutton P, The Navigation Guide Work Group. 2011. An evidence-based medicine methodology to bridge the gap between clinical and environmental health sciences. Health Aff 30(5):931-937.